Form 4 for ASTH Astrana Health, Inc.
Accepted 2025-10-06 00:00:00 ET · period of report 2025-10-02 · accession 0001104659-25-097117 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-06 | 2025-10-02 | ASTH | Basho Chandan | COO, CFO | F - Tax | $27.77 | -1,979 | 175.0K | -1% | -$55.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-02 | F | D | 1,979 | $27.77 | 174,967 | D | — | — | (F1) Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on October 2, 2025. (F2) Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 7,214 shares, which will vest on April 14, 2026; and (ii) 30,404 shares, which will vest in two equal annual installments on May 16, 2026 and 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 19,504 restricted stock units, which will vest in five equal semi-annual installments beginning on April 2, 2026; and (ii) 23,364 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026. |